News

Capital Market on MSN13m
Sun Pharma drops after Q4 PAT slides 19% YoY to Rs 2,1450 cr
Profit before tax (PBT) jumped 15.6% YoY to Rs 3,254.35 crore in Q4 FY25. During the quarter, EBITDA stood at Rs 3,716.1 ...
Vertex: Continuing To Dominate In CF, But What About Its Pain Pipeline?
Vertex Pharmaceuticals Incorporated is a Strong Buy with cystic fibrosis dominance, a diversified pipeline, and growth ...